Cephalon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CEPHALON, and what generic alternatives to CEPHALON drugs are available?
CEPHALON has eight approved drugs.
There are fifteen US patents protecting CEPHALON drugs.
There are two hundred and thirty-seven patent family members on CEPHALON drugs in thirty-five countries and fourteen supplementary protection certificates in five countries.
Summary for Cephalon
International Patents: | 237 |
US Patents: | 15 |
Tradenames: | 8 |
Ingredients: | 6 |
NDAs: | 8 |
Patent Litigation for Cephalon: | See patent lawsuits for Cephalon |
PTAB Cases with Cephalon as patent owner: | See PTAB cases with Cephalon as patent owner |
Drugs and US Patents for Cephalon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cephalon | TREANDA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 022249-003 | Sep 13, 2013 | DISCN | Yes | No | 8,445,524*PED | See Plans and Pricing | Y | See Plans and Pricing | |||
Cephalon | FENTANYL | fentanyl citrate | TROCHE/LOZENGE;ORAL | 020195-002 | Oct 4, 1993 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-002 | Sep 25, 2006 | RX | Yes | No | 7,862,832 | See Plans and Pricing | Y | See Plans and Pricing | |||
Cephalon | TREANDA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 022249-004 | Sep 13, 2013 | DISCN | Yes | No | 8,791,270*PED | See Plans and Pricing | Y | See Plans and Pricing | |||
Cephalon | NUVIGIL | armodafinil | TABLET;ORAL | 021875-003 | Jun 15, 2007 | AB | RX | Yes | No | 7,132,570*PED | See Plans and Pricing | Y | See Plans and Pricing | ||
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-002 | Sep 25, 2006 | RX | Yes | No | 8,119,158 | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cephalon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cephalon | FENTANYL | fentanyl citrate | TROCHE/LOZENGE;ORAL | 020195-001 | Oct 4, 1993 | 4,671,953 | See Plans and Pricing |
Cephalon | FENTANYL | fentanyl citrate | TROCHE/LOZENGE;ORAL | 020195-002 | Oct 4, 1993 | 4,671,953 | See Plans and Pricing |
Cephalon | ACTIQ | fentanyl citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 020747-005 | Nov 4, 1998 | 4,671,953 | See Plans and Pricing |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | 4,927,855*PED | See Plans and Pricing |
Cephalon | ACTIQ | fentanyl citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 020747-002 | Nov 4, 1998 | 4,863,737 | See Plans and Pricing |
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-002 | Dec 24, 1998 | 4,927,855*PED | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CEPHALON drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 100 mg and 200 mg | ➤ Subscribe | 2009-09-11 |
➤ Subscribe | Lozenges | 0.4 mg | ➤ Subscribe | 2004-10-06 |
➤ Subscribe | Lozenges | 0.8 mg, 1.2 mg and 1.6 mg | ➤ Subscribe | 2004-11-22 |
➤ Subscribe | Injection | 1 mg/mL | ➤ Subscribe | 2015-08-11 |
➤ Subscribe | Injection | 90 mg/mL, 0.5 mL and 2 mL in single-dose vials | ➤ Subscribe | 2014-06-19 |
➤ Subscribe | Tablets | 2 mg and 4 mg | ➤ Subscribe | 2005-02-01 |
➤ Subscribe | Tablets | 50 mg, 150 mg and 250 mg | ➤ Subscribe | 2009-07-24 |
➤ Subscribe | Lozenges | 0.2 mg | ➤ Subscribe | 2004-10-29 |
➤ Subscribe | Lozenges | 0.6 mg | ➤ Subscribe | 2004-12-20 |
➤ Subscribe | Injection | 25 mg/vial and 100 mg/vial | ➤ Subscribe | 2013-06-04 |
➤ Subscribe | Buccal Tablets | 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg and 0.8 mg | ➤ Subscribe | 2007-11-13 |
➤ Subscribe | Tablets | 12 mg and 16 mg | ➤ Subscribe | 2014-01-24 |
International Patents for Cephalon Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Eurasian Patent Organization | 200501016 | See Plans and Pricing |
South Korea | 20180056804 | See Plans and Pricing |
European Patent Office | 2271315 | See Plans and Pricing |
Canada | 2549642 | See Plans and Pricing |
South Africa | 200504805 | See Plans and Pricing |
Canada | 2548915 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cephalon Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0236342 | SPC/GB98/022 | United Kingdom | See Plans and Pricing | PRODUCT NAME: TIAGABINE ( INCLUDING SALTS THEREOF ); REGISTERED: FR AMM NO. 341 260.2 19960614; FR AMM NO. 341 262.5 19960614; FR AMM NO. 341 264.8 19960614; UK 03132/0117 19971111; UK 03132/0118 19971111; UK 03132/0119 19971111 |
1635783 | CA 2014 00016 | Denmark | See Plans and Pricing | PRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831 |
1769785 | C300521 | Netherlands | See Plans and Pricing | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
1635783 | 300653 | Netherlands | See Plans and Pricing | PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906 |
0836511 | SPC/GB06/022 | United Kingdom | See Plans and Pricing | PRODUCT NAME: FENTANYL HYDROCHLORIDE; REGISTERED: UK EU/1/05/326/001 20060124 |
0836511 | 122006000022 | Germany | See Plans and Pricing | PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.